非酒精性脂肪肝疾病和冠状动脉疾病:基于内皮功能障碍的双向关联
Nikolaos Ktenopoulos1, Marios Sagris1, Maria Gerogianni2,3
1First Department of Cardiology, 'Hippokration' General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.
International journal of molecular sciences
|October 16, 2024
概括
非酒精性脂肪肝疾病 (NAFLD) 与内皮功能障碍 (EnD) 有关,增加了心血管疾病 (CAD) 的风险. 了解这些联系有助于制定更好的NAFLD和CAD管理策略.
科学领域:
- 肝病学和心脏病学.
- 代谢综合征研究 代谢综合征研究
- 血管生物学 血管生物学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 是慢性肝病的主要原因,也是代谢综合征的关键指标.
- NAFLD与胰岛素抵抗,肥胖和糖尿病有关,从而增加心血管疾病 (CAD) 的风险.
- 内皮功能障碍 (EnD) 是动脉样硬化和CAD发展的主要因素.
研究的目的:
- 调查NAFLD和CAD之间的关联,专注于内皮功能障碍 (EnD) 的作用.
- 探索与NAFLD,EnD和CAD联系的病理生理机制和遗传因素.
- 审查当前的管理策略和对优化患者治疗的临床影响.
主要方法:
- 对检查NAFLD,EnD和CAD的研究进行文献综述.
- 对病理生理路径和分子机制的分析.
- 讨论遗传倾向和治疗方法.
主要成果:
- NAFLD与内皮功能障碍 (EnD) 密切相关,内皮功能障碍是动脉样硬化和冠状动脉疾病 (CAD) 进展的关键调解者.
- 共同的代谢和炎症途径有助于NAFLD患者的EndD的发展.
- 遗传因素可能会影响这些相互关联的疾病的易感性和严重程度.
结论:
- 内皮功能障碍 (EnD) 是非酒精性脂肪肝疾病 (NAFLD) 和冠状动脉疾病 (CAD) 之间的关键联系.
- 针对代谢综合征成分的综合管理策略对于NAFLD和CAD患者至关重要.
- 为了改善临床结果,需要对遗传因素和新型治疗点进行进一步的研究.
相关概念视频
01:26Coronary Artery Disease II: Pathophysiology
3
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3
01:30Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
01:26Coronary Artery Disease IV: Medical Management
4
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
4
01:26Atherosclerosis III: Management
2
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
2
01:30Peripheral Artery Disease I: Introduction
3
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
3
01:30Atherosclerosis I: Introduction
2
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2